Evidence map›Paper›PMID 34133928›Full record

ArticleCell reports2021

VEGFC/FLT4-induced cell-cycle arrest mediates sprouting and differentiation of venous and lymphatic endothelial cells.

Ayelet Jerafi-Vider, Ivan Bassi, Noga Moshe, Yaara Tevet, Gideon Hen, Daniel Splittstoesser, Masahiro Shin, Nathan D Lawson, Karina Yaniv

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. A who's who of cell types in skeletal muscle.Communications biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. NARFL Knockout Triggers Ferroptosis-Driven Vascular Endothelial Dysfunction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Regulation of VEGFR3 signaling in lymphatic endothelial cells.Frontiers in cell and developmental biology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Central conducting lymphatic anomaly: from bench to bedside.The Journal of clinical investigation · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ayelet Jerafi-ViderDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Ivan BassiDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Noga MosheDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Yaara TevetDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Gideon HenDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Daniel SplittstoesserDepartment of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Masahiro ShinDepartment of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Nathan D LawsonDepartment of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Karina YanivDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: karina.yaniv@weizmann.ac.il.
Weizmann Institute of Science · ILUniversity of Massachusetts Chan Medical School · US

Funding

Embryonic origins of endothelial heterogeneityR35HL140017 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LAWSON, NATHAN D · 2018 to 2023
$6.0M
NHLBI NIH HHS R35 HL140017
6 · The paper itself

Abstract

The formation of new vessels requires a tight synchronization between proliferation, differentiation, and sprouting. However, how these processes are differentially activated, often by neighboring endothelial cells (ECs), remains unclear. Here, we identify cell cycle progression as a regulator of EC sprouting and differentiation. Using transgenic zebrafish illuminating cell cycle stages, we show that venous and lymphatic precursors sprout from the cardinal vein exclusively in G1 and reveal that cell-cycle arrest is induced in these ECs by overexpression of p53 and the cyclin-dependent kinase (CDK) inhibitors p27 and p21. We further demonstrate that, in vivo, forcing G1 cell-cycle arrest results in enhanced vascular sprouting. Mechanistically, we identify the mitogenic VEGFC/VEGFR3/ERK axis as a direct inducer of cell-cycle arrest in ECs and characterize the cascade of events that render "sprouting-competent" ECs. Overall, our results uncover a mechanism whereby mitogen-controlled cell-cycle arrest boosts sprouting, raising important questions about the use of cell cycle inhibitors in pathological angiogenesis and lymphangiogenesis.

Indexed as

Cell Cycle CheckpointsEndothelial CellsLymphatic VesselsNeovascularization, PhysiologicVascular Endothelial Growth Factor CVeinsZebrafish ProteinsAnimalsAnimals, Genetically ModifiedCell DifferentiationG1 PhaseMAP Kinase Signaling SystemRoscovitineVascular Endothelial Growth Factor Receptor-3Zebrafishflt4 protein, zebrafishRoscovitineVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3Zebrafish Proteins

Identifiers

PMID34133928
PMCPMC8220256
OpenAlexW3170814343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.